Table 2.
Patients outcomes in patients with or without diaphragm atrophy
| Variable | Patient outcomes according to three groups of diaphragm thickness evolution (: stable, atrophy, increase) using a ultrasound method | Patient outcomes according to the absence or the presence of diaphragm atrophy using a ultrasound method | |||||
|---|---|---|---|---|---|---|---|
| Increase, N = 41 | Decrease, N = 71 | Stable, N = 181 | p-value2 | Non-atrophy, N = 221 | Atrophy, N = 71 | p-value3 | |
| Deceased before VA-ECMO weaning | 1 (25%) | 3 (43%) | 4 (22%) | 0.7 | 5 (23%) | 3 (43%) | 0.4 |
| VA-ECMO weaning failure | 1 (25%) | 4 (57%) | 7 (39%) | 0.6 | 8 (36%) | 4 (57%) | 0.4 |
| VA-ECMO days | 5 [3.8, 7] | 4 [2, 6] | 6.5 [4, 11] | 0.2 | 6 [4, 10] | 4 [2, 6] | 0.10 |
| Days with mechanical ventilation | 4 [2, 5] | 8 [7, 20] | 5 [1, 11] | 0.059 | 5 [1, 10] | 8 [7, 20] | 0.029 |
| Ventilator free days at day 60 | 55 [40, 58] | 7 [0, 29] | 54 [20, 59] | 0.056 | 54 [20, 59] | 7 [0, 29] | 0.018 |
| Deceased at day 60 | 1 (25%) | 5 (71%) | 4 (22%) | 0.063 | 5 (23%) | 5 (71%) | 0.030 |
| Deceased at day 7 | 1 (25%) | 3 (43%) | 1 (5.6%) | 0.059 | 2 (9.1%) | 3 (43%) | 0.075 |
Results are reported for patients according to their diaphragm evolution status at the end of patient follow up. The population was divided in three categories whether the diaphragm thickness presented a 10% decrease, increase or remained stable from baseline to the last assessment. Outcomes are presented after 60 days of follow-up (unless otherwise specified)
1n (%); Median [interquartile range]
2Fisher’s exact test; Kruskal–Wallis rank sum test
3Fisher’s exact test; Wilcoxon rank sum test